Cressant Arnaud, Dubreuil Veronique, Kong Jing, Kranz Thorsten Manfred, Lazarini Francoise, Launay Jean-Marie, Callebert Jacques, Sap Jan, Malaspina Dolores, Granon Sylvie, Harroch Sheila
Neurobiologie de la prise de décision, Paris-Saclay Institute of Neuroscience (Neuro-PSI), CNRS UMR 9197 and Université Paris Sud, Orsay, France.
Department of Neuroscience, Institut Pasteur, 75724, Paris, France.
Psychopharmacology (Berl). 2017 Feb;234(4):575-587. doi: 10.1007/s00213-016-4490-8. Epub 2016 Dec 26.
The receptor protein tyrosine phosphatase PTPRG has been genetically associated with psychiatric disorders and is a ligand for members of the contactin family, which are themselves linked to autism spectrum disorders.
Based on our finding of a phosphatase-null de novo mutation in PTPRG associated with a case of sporadic schizophrenia, we used PTPRG knockout (KO) mice to model the effect of a loss-of-function mutation. We compared the results with loss-of-function in its close paralogue PTPRZ, previously associated with schizophrenia. We tested PTPRG , PTPRZ , and wild-type male mice for effects on social behavior, forced swim test, and anxiety, as well as on regional brain neurochemistry.
The most notable behavioral consequences of PTPRG gene inactivation were reduced immobilization in the forced swim test, suggestive of some negative symptoms of schizophrenia. By contrast, PTPRZ mice demonstrated marked social alteration with increased aggressivity, reminiscent of some positive symptoms of schizophrenia. Both knockouts showed elevated dopamine levels in prefrontal cortex, hippocampus, and most particularly amygdala, but not striatum, accompanied by reduced dopamine beta hydroxylase activity only in amygdala. In addition, PTPRG KO elicited a distinct increase in hippocampal serotonin level not observed in PTPRZ KO.
PTPRG and PTPRZ gene loss therefore induces distinct patterns of behavioral change and region-specific alterations in neurotransmitters, highlighting their usefulness as models for neuropsychiatric disorder mechanisms and making these receptors attractive targets for therapy.
受体蛋白酪氨酸磷酸酶PTPRG在基因层面与精神疾病相关,并且是接触蛋白家族成员的配体,而接触蛋白家族自身与自闭症谱系障碍有关。
基于我们在一例散发性精神分裂症患者中发现的与PTPRG基因缺失相关的新生突变,我们使用PTPRG基因敲除(KO)小鼠来模拟功能丧失突变的影响。我们将结果与之前与精神分裂症相关的紧密旁系同源基因PTPRZ的功能丧失结果进行了比较。我们测试了PTPRG、PTPRZ和野生型雄性小鼠在社交行为、强迫游泳试验、焦虑以及区域脑神经化学方面的影响。
PTPRG基因失活最显著的行为后果是在强迫游泳试验中不动时间减少,这提示了精神分裂症的一些阴性症状。相比之下,PTPRZ基因敲除小鼠表现出明显的社交改变,攻击性增加,并伴有精神分裂症阳性症状。两种基因敲除小鼠在前额叶皮质、海马体,尤其是杏仁核中多巴胺水平升高,但纹状体中没有,同时仅在杏仁核中多巴胺β羟化酶活性降低。此外,PTPRG基因敲除导致海马体中血清素水平显著升高,而PTPRZ基因敲除小鼠未出现这种情况。
因此,PTPRG和PTPRZ基因缺失会引发不同模式的行为变化和神经递质的区域特异性改变,突出了它们作为神经精神疾病机制模型的有用性,并使这些受体成为有吸引力的治疗靶点。